A multicentre evaluation of a new chitosan FHO2™ spray-on dressing patients with chronic wounds in the UK.

Chronic wounds such as venous leg ulcers and diabetic foot ulcers are increasing in prevalence and impose a significant burden on patients and the NHS alike, particularly if complications related to delayed healing occur, such as infection, cellulitis or amputation. LQD® wound spray is a new primary...

Full description

Bibliographic Details
Published in:Journal of Community Nursing Vol. 32; no. 3; pp. 30 - 37
Main Authors: Sharpe, Andrew, Tickle, Joy, Hampton, Sylvie, Gray, David
Format: case study pictorial research tables/charts Journal Article
Published: Wound Care People Limited Jun2018
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=130856669&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 130856669
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20595417
        G7D
      jtl: Journal of Community Nursing
      issn: 20595417
      maglogo: N
    pubinfo:
      dt: Jun2018
      vid: 32
      iid: 3
      pid: 88648
      pub: Wound Care People Limited
    artinfo:
      ui:
        130856669
        130856669
        130856669
        130856669
      ppf: 30
      ppct: 7
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: A multicentre evaluation of a new chitosan FHO2™ spray-on dressing patients with chronic wounds in the UK.
      aug:
        au:
          Sharpe, Andrew
          Tickle, Joy
          Hampton, Sylvie
          Gray, David
        affil: Advanced Podiatrist, Blackpool Teaching Hospitals NHS Foundation Trust
      sug:
        subj:
          Wounds, Chronic Therapy
          Antimicrobial Dressings Evaluation
          Wound Healing
          Hydrogel Dressings Evaluation
          Treatment Outcomes
          Male
          Female
          Human
          Leg Ulcer Drug Therapy
          Patient Satisfaction
          Cost Benefit Analysis
          Male
          Female
      ab: Chronic wounds such as venous leg ulcers and diabetic foot ulcers are increasing in prevalence and impose a significant burden on patients and the NHS alike, particularly if complications related to delayed healing occur, such as infection, cellulitis or amputation. LQD® wound spray is a new primary dressing that contains chitosan FH02™. A multicentre evaluation was carried out across four centres in the UK to determine the efficacy of LQD in promoting wound healing in patients with long-standing venous leg ulcers and diabetic foot ulcers (n=39). The evaluation found that LQD promoted wound healing in almost half of the wounds (n=18), and 15 wounds made significant progress towards healing as measured by reduced wound dimensions and an increase in the healthy wound tissue present. Two wounds remained unchanged. Patients and clinicians reported that the use of LQD had a positive impact on wound progress.
      pubtype: Academic Journal
      doctype:
        case study
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N